Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Why ZIM Integrated Shipping Services Shares Are Trading Lower By 14%? Here Are Other Stocks Moving In Monday's Mid-Day Session

Author: Lisa Levin | May 22, 2023 01:20pm

Gainers

  • Greenhill & Co., Inc. (NYSE:GHL) shares jumped 116.4% to $14.67 after Mizuho announced it would acquire the company for $15 per share.
  • AVROBIO, Inc. (NASDAQ:AVRO) gained 93.5% to $1.50 after the company announced it would sell its gene therapy program to Novartis for $87.5 million.
  • Microbot Medical Inc. (NASDAQ:MBOT) rose 66% to $2.0450 after the company announced it achieved a 100% success rate for the LIBERTY system in an extensive pre-clinical animal study performed by leading European physicians.
  • Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA) shares gained 39.7% to $12.45 after the company announced results of its phase 2 study to treat liver function.
  • VectivBio Holding AG (NASDAQ:VECT) climbed 38.5% to $16.20 after Ironwood Pharmaceuticals announced it would acquire the company for $17 per share.
  • Atea Pharmaceuticals, Inc. (NASDAQ:AVIR) shares climbed 33.5% to $4.9375. Tang Capital Partners, Concentra sent acquisition proposal to Atea Pharmaceuticals with terms to acquire all of its outstanding common stock.
  • Appreciate Holdings, Inc. (NASDAQ:SFR) gained 30% to $0.3551. Appreciate announced receipt of notice from Nasdaq regarding late filing of its form 10-Q and 10-K.
  • D-Wave Quantum Inc. (NYSE:QBTS) surged 25.5% to $0.6080. Benchmark reiterated D-Wave Quantum with a Buy and maintained a $2 price target.
  • CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) shares climbed 24.3% to $1.9850 after gaining around 18% on Friday. CNS Pharmaceuticals posted a wider first-quarter loss.
  • SeqLL Inc. (NASDAQ:SQL) shares climbed 23.9% to $0.4149 after dropping 14% on Friday. SeqLL recently posted a wider first-quarter loss.
  • Cricut, Inc. (NASDAQ:CRCT) gained 22.2% to $8.78. Cricut declared a $234 million special cash dividend of $1/share to holders of the company’s Class A and Class B common stock.
  • Yunji Inc. (NASDAQ:YJ) gained 19.8% to $0.22.
  • Histogen Inc. (NASDAQ:HSTO) rose 18.7% to $1.00.
  • Absci Corporation (NASDAQ:ABSI) jumped 18.7% to $1.65.
  • ADS-TEC Energy PLC (NASDAQ:ADSE) rose 18.6% to $7.13.
  • Akebia Therapeutics, Inc. (NASDAQ:AKBA) climbed 18.1% to $1.37 after the company announced UK MHRA approval of Vafseo for the treatment of symptomatic anemia associated with chronic kidney disease in adults on chronic maintenance dialysis.
  • Peraso Inc. (NASDAQ:PRSO) gained 17.3% to $0.3050. Benchmark maintained Peraso with a Buy and lowered the price target from $2.5 to $1.5.
  • Outlook Therapeutics, Inc. (NASDAQ:OTLK) rose 17.2% to $1.57.
  • Rackspace Technology, Inc. (NASDAQ:RXT) jumped 16.6% to $1.3185.
  • Netcapital Inc. (NASDAQ:NCPL) shares gained 16.1% to $2.29 after gaining over 6% on Friday.
  • Upstart Holdings, Inc. (NASDAQ:UPST) jumped 14.6% to $26.41.
  • Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) surged 14.5% to $7.36.
  • CI&T Inc (NASDAQ:CINT) gained 14.2% to $4.0750. CI&T recently reported Q1 financial results.
  • ZyVersa Therapeutics, Inc. (NASDAQ:ZVSA) rose 13.1% to $0.4821 after the company reported changes to ZyVersa’s board of directors.
  • IonQ, Inc. (NASDAQ:IONQ) gained 13% to $10.04.
  • Nanobiotix S.A. (NASDAQ:NBTX) gained 12.5% to $5.25. NANOBIOTIX recently issued an update on operational progress and reported financial results for the for the first quarter.
  • Kodiak Sciences Inc. (NASDAQ:KOD) climbed 12.2% to $6.63. Kodiak Sciences recently reported a year-over-year increase in first-quarter EPS.
  • Celularity Inc. (NASDAQ:CELU) shares climbed 9.6% to $0.7124. Celularity highlighted presentation of Phase 1 data on MLASC therapy in patients with Crohn's Disease.
  • Immix Biopharma, Inc. (NASDAQ:IMMX) shares rose 8.5% to $1.7812 after the company announced NXC-201 clinical results showed 100% overall response rate in DARZALEX-relapsed or refractory AL amyloidosis with zero ICANs in the ongoing NEXICART-1 Phase 1b/2a trial.
  • NIO Inc. (NYSE:NIO) gained 7.7% to $8.69 after the Chinese government announced interest rates would remain unchanged.

Losers

  • Rain Oncology Inc. (NASDAQ:RAIN) shares dipped 87.3% to $1.2700 after the company’s Phase 3 MANTRA trial of milademetan in dedifferentiated liposarcoma, did not meet its primary endpoint of progression-free survival, compared to the standard of care, trabectedin.
  • Mallinckrodt plc (NYSE:MNK) fell 45.1% to $3.46.
  • Monogram Orthopaedics, Inc. (NASDAQ:MGRM) dropped 36% to $8.65.
  • Volcon, Inc. (NASDAQ:VLCN) fell 34.5% to $0.7125 as the company reported $9 million in securities offerings and pricing of previously announced public offering.
  • Bright Health Group, Inc. (NYSE:BHG) dropped 27% to $12.18.
  • Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT) fell 24.3% to $10.27. FDA's Gastrointestinal Drugs Advisory Committee voted 12 to 2—with two abstentions—that the benefits of Intercept Pharmaceuticals’ Ocaliva 25 mg, also known as Obeticholic acid (OCA), don't outweigh the risks in nonalcoholic steatohepatitis (NASH) patients with stage 2 or 3 fibrosis.
  • Daxor Corporation (NASDAQ:DXR) shares dropped 23.1% to $9.61 after the company reported pricing of $4.0 million underwritten public offering.
  • SunCar Technology Group Inc. (NASDAQ:SDA) fell 22.5% to $6.03 amid continued volatility following the recent completion of the company's combination with Goldenbridge Acquisition to become a publicly-traded company.
  • Enveric Biosciences, Inc. (NASDAQ:ENVB) dipped 21.2% to $2.79. Enveric Biosciences announced manuscript detailing the development of novel psilocin prodrugs for the treatment of anxiety and other mental health disorders.
  • Interactive Strength Inc. (NASDAQ:TRNR) fell 20.7% to $5.61.
  • Sigilon Therapeutics, Inc. (NASDAQ:SGTX) fell 18.3% to $0.51 after the company announced a 1-for-13 reverse stock split.
  • Bluejay Diagnostics, Inc. (NASDAQ:BJDX) dropped 17.5% to $0.2303.
  • WaveDancer, Inc. (NASDAQ:WAVD) dipped 16% to $0.3359.
  • Ault Alliance, Inc. (NYSE:AULT) dropped 15.3% to $12.45. Ault Alliance and BitNile Metaverse launched social gaming on the platform with the launch of Online Roulette.
  • ZIM Integrated Shipping Services Ltd. (NYSE:ZIM) dipped 13.9% to $15.07 after the company reported a year-over-year decrease in first-quarter EPS results and worse-than-expected sales results.
  • Baudax Bio, Inc. (NASDAQ:BXRX) fell 13.2% to $0.55. Baudax Bio recently posted a first-quarter loss of $3.19 per share.
  • Biocept, Inc. (NASDAQ:BIOC) shares dropped 10.1% to $5.98. Biocept recently announced a 1-for-30 reverse stock split..
  • Nutex Health Inc. (NASDAQ:NUTX) fell 8.7% to $0.5081.
  • Flora Growth Corp. (NASDAQ:FLGC) fell 8% to $0.2392 after surging 8% on Friday. Flora Growth recently posted a narrower-than-expected quarterly loss.
  • The Vita Coco Company, Inc. (NASDAQ:COCO) dropped 7.6% to $22.57 after the company reported a secondary offering of 4.5 million shares of common stock by selling stockholder.
  • Icahn Enterprises L.P. (NASDAQ:IEP) fell 5.8% to $30.33.
  • Micron Technology, Inc. (NASDAQ:MU) shares dropped 4.1% to $65.43 after China banned some of its product sales after a seven-week investigation into Micron.

Now Read This: Ethereum Trades Above $1,800; TRON Becomes Top Gainer

Posted In: ABSI ADSE AKBA AULT AVIR AVRO BHG BIOC BJDX BXRX CELU CINT CNSP COCO CRCT DXR ENVB FLGC GHL HEPA


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist